Navigating adalimumab biosimilars: an expert opinion.
adalimumab
biosimilar
device
dose
efficacy
formulation
nocebo
patient expectations
patient–physician communication
safety
Journal
Journal of comparative effectiveness research
ISSN: 2042-6313
Titre abrégé: J Comp Eff Res
Pays: England
ID NLM: 101577308
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
medline:
2
11
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
ppublish
Résumé
The patent expiry of Humira
Identifiants
pubmed: 37855223
doi: 10.57264/cer-2023-0117
pmc: PMC10690439
doi:
Substances chimiques
Adalimumab
FYS6T7F842
Biosimilar Pharmaceuticals
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e230117Références
Arthritis Rheumatol. 2018 Jun;70(6):832-840
pubmed: 29439289
J Crohns Colitis. 2020 Jun 19;14(5):680-685
pubmed: 31875891
Br J Dermatol. 2018 Sep;179(3):623-631
pubmed: 29917226
Arthritis Res Ther. 2019 Dec 12;21(1):281
pubmed: 31831079
RMD Open. 2021 Apr;7(2):
pubmed: 33883254
Arthritis Rheumatol. 2018 Jan;70(1):40-48
pubmed: 28950421
Biotechnol Bioeng. 2017 Dec;114(12):2696-2705
pubmed: 28842986
Arthritis Care Res (Hoboken). 2010 Dec;62(12):1815
pubmed: 20665747
Ann Pharmacother. 1996 Jul-Aug;30(7-8):729-32
pubmed: 8826549
Arthritis Res Ther. 2021 Feb 5;23(1):51
pubmed: 33546755
Rheumatology (Oxford). 2019 Feb 1;58(2):e43-e45
pubmed: 30500917
BioDrugs. 2019 Jun;33(3):241-253
pubmed: 31111422
Semin Arthritis Rheum. 2022 Dec;57:152119
pubmed: 36341778
BioDrugs. 2021 Nov;35(6):735-748
pubmed: 34657274
Clin Exp Rheumatol. 2023 Mar;41(3):613-619
pubmed: 35916302
Am J Manag Care. 2022 Nov;28(12 Suppl):S227-S233
pubmed: 36493396
J Pharm Sci. 2017 Mar;106(3):713-733
pubmed: 27894967
Int J Pharm. 2019 Jan 10;554:376-386
pubmed: 30414478
J Diabetes Sci Technol. 2012 Mar 01;6(2):328-35
pubmed: 22538142
Ann Rheum Dis. 2017 Oct;76(10):1679-1687
pubmed: 28584187
Front Pharmacol. 2019 Nov 29;10:1372
pubmed: 31849647
Rheumatol Ther. 2016 Dec;3(2):257-270
pubmed: 27747583
BioDrugs. 2020 Oct;34(5):695-698
pubmed: 32949384
Br J Dermatol. 2020 Feb;182(2):316-326
pubmed: 31206593
Gastroenterol Hepatol. 2020 Jan;43(1):9-13
pubmed: 31492425
Rheumatology (Oxford). 2017 Aug 1;56(suppl_4):iv4-iv13
pubmed: 28903545
United European Gastroenterol J. 2023 Mar;11(2):179-188
pubmed: 36802176
Arthritis Res Ther. 2018 Aug 15;20(1):178
pubmed: 30111357
Dermatol Ther. 2020 Mar;33(2):e13240
pubmed: 32012405
J Pharm Sci. 2016 Aug;105(8):2255-9
pubmed: 27378678
Am J Manag Care. 2023 Feb;29(2):78-80
pubmed: 36811981
Rheumatology (Oxford). 2022 Apr 11;61(4):1385-1395
pubmed: 34142111
Br J Dermatol. 2017 Dec;177(6):1562-1574
pubmed: 28755394
J Dermatolog Treat. 2023 Dec;34(1):2140569
pubmed: 36305624
J Diabetes Sci Technol. 2018 Jan;12(1):163-168
pubmed: 28990437
Rheumatol Ther. 2020 Dec;7(4):741-757
pubmed: 33206343
Drugs. 2021 Nov;81(16):1859-1879
pubmed: 34705255
Cutis. 2018 Aug;102(2):116-118
pubmed: 30235360
Somatosens Mot Res. 2006 Mar-Jun;23(1-2):37-43
pubmed: 16846958
Front Med (Lausanne). 2022 Jan 27;9:799494
pubmed: 35155495
Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3300-3305
pubmed: 33928613
J Am Acad Dermatol. 2017 Jun;76(6):1093-1102
pubmed: 28291552
J Pharm Sci. 2021 Apr;110(4):1572-1582
pubmed: 33556387